Workshop report204th ENMC International Workshop on Biomarkers in Duchenne Muscular Dystrophy 24-26 January 2014, Naarden, The Netherlands

•An overview on the state-of-the-art of known and new biomarkers in DMD was presented.•The strategies to identify biomarkers using standard and novel technologies were compared.•The need to correlate outcome measures with biomarkers was established.•The relevance of dystrophin as biomarker in clinical trials was pointed out.•The importance of sharing data via registries and biorepositories was underlined.